CML Community Advisory Board (CML-CAB) Meeting 2021

CML Community Advisory Board (CML-CAB) Meeting 2021 On 18 February 2021, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted it´s first meeting of the year. It was the 12th CML Community Advisory Board (CML-CAB) and 22nd...

CML-CAB Resources

CML-CAB Meetings: Based on the proven ECAB model implemented by the HIV patient community and EATG for morethan a decade, the first CML-CAB was held in May 2016. Since then, we have carried out 12 CMLCABs in 22 sessions (2016-2021).  12 CML-CABs in 22 sessions from...

CML-CAB Objectives & Strategy

CML-CAB Objectives & Strategy   The CML-CAB objectives are: Providing researchers, academics, government, policy makers, authorities and the pharmaceutical industry with advice and input on different issues that impact on patients’ lives Promoting...

Composition of CML-CAB

Composition of CML-CAB It falls within the responsibility of the CML-CAB chairs to determine how many and which members from the CML-CAB member pool (and potentially others) will be invited to specific CAB-meetings. The CML-CAB chairs will select participants based on...

How do CABs work?

How do CABs work?   CML-CAB invites participants from the companies CML-CAB sets the agenda for a two-way dialogue and pick the topics that are most meaningful to us CML-CAB respects confidentiality to have a trusted and open dialogue CML-CAB reports to...

Why CML Community Advisory Boards (CML-CABs)?

Why CML Community Advisory Boards (CML-CABs)?   Research is key towards better outcomes, but often the trials are done without patient input, do not deliver on unmet needs, to not deliver patient-relevant data (e.g. PRO, QoL), are run in the wrong countries, do...